Safety of Contrast Agent Use During Stress Echocardiography-Reference-Cited by-同舟云学术

Safety of Contrast Agent Use During Stress Echocardiography

Published:2009-09 Issue:9 Volume:2 Page:1048-1056
ISSN:1936-878X
Container-title:JACC: Cardiovascular Imaging
language:en
Short-container-title:JACC: Cardiovascular Imaging

Author:

Abdelmoneim Sahar S.,Bernier Mathieu,Scott Christopher G.,Dhoble Abhijeet,Ness Sue Ann C.,Hagen Mary E.,Moir Stuart,McCully Robert B.,Pellikka Patricia A.,Mulvagh Sharon L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Reference20 articles.

1. Contrast dobutamine stress echocardiography: clinical practice assessment in 300 consecutive patients;Rainbird;J Am Soc Echocardiogr,2001

2. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent: results of a phase III Multicenter Trial;Cohen;J Am Coll Cardiol,1998

3. Efficacy and safety of the novel ultrasound contrast agent perflutren (Definity) in patients with suboptimal baseline left ventricular echocardiographic images;Kitzman;Am J Cardiol,2000

4. American Society of Echocardiography consensus statement on the clinical applications of ultrasonic contrast agents in echocardiography;Mulvagh;J Am Soc Echocardiogr,2008

5. Stress echocardiography;Pellikka;Mayo Clin Proc,1995

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restoring microvascular circulation with diagnostic ultrasound and contrast agent: rationale and design of the REDUCE trial;American Heart Journal;2024-09

2. Sonothrombolysis Before and After Percutaneous Coronary Intervention Provides the Largest Myocardial Salvage in ST Segment Elevation Myocardial Infarction;Journal of the American Society of Echocardiography;2024-07

3. Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice;Journal of the American Society of Echocardiography;2023-10

4. Low-Dose Application of Ultrasound-Enhancing Agents Without Flush in Echocardiography: Prospective Experience From the Edmonton Cancer Registry;Journal of the American Society of Echocardiography;2023-10

5. Safety of Lumason® (SonoVue®) in special populations and critically ill patients;Frontiers in Cardiovascular Medicine;2023-08-02